Advanced Therapies in Crohn's Disease

BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Omvoh™/Eli Lilly and Company/LillyPlus® (2025)

CLASS

Interleukin-23 (IL-23) inhibitor

ACTION

Humanized immunoglobulin G4 (IgG4) monoclonal antibody that binds with high affinity and specificity to the p19 subunit of human IL-23 cytokine and inhibits its interaction with the IL-23 receptor.